Skip to main content
. 2011 Dec 14;6(12):e28720. doi: 10.1371/journal.pone.0028720

Figure 2. Distribution of FITC-labeled PNIPAM nanoparticles after intravitreous administration over a day.

Figure 2

Localization of fluorescence in the posterior segments of the eye at various time points (2, 4 and 24 hours) was observed (A) and quantified (B). Quantification of the normalized fluorescence intensity at various locations (TB: Trabecular Meshwork; RA: Retina; ON: Optic Nerve) at various time points (C).